GAM
JAZZ icon

Guinness Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Guinness Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
2,730
+247
+10% +$54.1K 0.01% 85
2026
Q1 		$469K Sell
2,483
-305
-11% -$53.3K 0.01% 92
2025
Q4 		$475K Sell
2,788
-512
-16% -$78.5K 0.01% 94
2025
Q3 		$426K Buy
+3,300
New +$396K 0.01% 93

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Guinness Asset Management's JAZZ Position: Q2 2026 in Review

Guinness Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 9.9% in Q2 2026, buying an estimated $54.1K and bringing the position to 2,730 shares worth $658K. The position accounts for 0.01% of the portfolio, ranked #85.

Guinness Asset Management first reported a position in JAZZ in Q3 2025 and has held it in 4 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Guinness Asset Management held 2,730 shares of Jazz Pharmaceuticals worth $658K as of Q2 2026.
  • Guinness Asset Management bought 247 Jazz Pharmaceuticals shares in Q2 2026, an estimated $54.1K.
  • Jazz Pharmaceuticals made up 0.01% of Guinness Asset Management's portfolio in Q2 2026, its #85 holding.
  • Guinness Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Guinness Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.